PD-L1 NEGATIVE

Clinical trials for PD-L1 NEGATIVE explained in plain language.

Never miss a new study

Get alerted when new PD-L1 NEGATIVE trials appear

Sign up with your email to follow new studies for PD-L1 NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug shows promise in Tough-to-Treat breast cancer

Disease control Ongoing

This study tests a drug called sacituzumab govitecan against standard chemotherapy in people with advanced triple-negative breast cancer that does not have a protein called PD-L1. The goal is to see if the new drug can delay cancer growth or improve survival. About 623 participan…

Matched conditions: PD-L1 NEGATIVE

Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control

Last updated May 22, 2026 14:02 UTC

PD-L1 NEGATIVE

Get alerted when new PD-L1 NEGATIVE trials appear

New drug shows promise in Tough-to-Treat breast cancer